Blend Labs (NYSE: BLND) holder files to sell 2,500 shares under Rule 144

Rhea-AI Filing Summary

Blend Labs has a planned sale of restricted shares under Rule 144. A shareholder filed notice to sell 2,500 shares of common stock through Charles Schwab on or about January 7, 2026 on the NYSE, with an indicated aggregate market value of $7,725.00.

The shares were originally acquired from Blend Labs, Inc. on May 20, 2025 through a restricted stock lapse as equity compensation. As of the filing, Blend Labs reported 256,119,535 shares of common stock outstanding, which is a baseline ownership figure rather than the amount being sold.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	2500	7725.00	256119535	01/07/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/20/2025	Restricted Stock Lapse	BLEND LABS, INC.			2500	05/20/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the latest BLND Rule 144 notice disclose?

The notice discloses a plan to sell 2,500 shares of Blend Labs common stock through Charles Schwab & Co., Inc. on or about January 7, 2026 on the NYSE.

How many Blend Labs (BLND) shares are planned for sale and at what value?

The filing reports an intended sale of 2,500 common shares of Blend Labs with an indicated aggregate market value of $7,725.00.

How were the BLND shares being sold under Rule 144 originally acquired?

The 2,500 Blend Labs common shares were acquired on May 20, 2025 via a restricted stock lapse from Blend Labs, Inc. as equity compensation.

What is the total number of Blend Labs (BLND) shares outstanding referenced in the notice?

The notice states that 256,119,535 shares of Blend Labs common stock were outstanding, which serves as a baseline ownership figure.

Which broker and exchange are involved in the planned BLND share sale?

The planned sale of Blend Labs common stock is listed through Charles Schwab & Co., Inc. with trading on the NYSE.

What type of transaction is reported for the BLND shares in this filing?

The transaction is a planned sale of restricted stock that became unrestricted via a restricted stock lapse, reported under Rule 144 with the consideration labeled as equity compensation.